Compass Therapeutics: Q1 Earnings Insights

Comments
Loading...

Compass Therapeutics CMPX reported its Q1 earnings results on Thursday, May 4, 2023 at 08:30 AM.

Here's what investors need to know about the announcement.

Earnings

Compass Therapeutics beat estimated earnings by 45.45%, reporting an EPS of $-0.06 versus an estimate of $-0.11.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 3.93% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Compass Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

CMPX Logo
CMPXCompass Therapeutics Inc
$2.692.67%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum94.95
Growth-
Quality-
Value1.92
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: